Gastrointestinal bleeding associated with rivaroxaban administration in a treated patient infected with human immunodeficiency virus

The use of rivaroxaban in fixed dosing regimens without need for routine coagulation monitoring may lead to the misconception that there is a minimal risk of drug-drug interactions. We describe the case of a patient infected with human immunodeficiency virus (HIV) on salvage therapy who develo...

Full description

Bibliographic Details
Main Authors: Botond Lakatos, Marcel Stoeckle, Luigia Elzi, Manuel Battegay, Catia Marzolini
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2014-01-01
Series:Swiss Medical Weekly
Subjects:
Online Access:https://www.smw.ch/index.php/smw/article/view/1809